Drug Discovery

We had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Sitting Down With… Theresa Heah, CEO, Intergalactic Therapeutics, Cambridge, Massachusetts

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors

How AI-based research tools can empower researchers and dive deeper into data

PULSED – a self-sealing drug delivery depot – enables precise timing and tunable release of therapeutic doses

Is safeguard sgRNA the key to reducing the off-target effects of gene editing, while increasing its potential applications?

Why automated synthetic biology solutions can pave the way forward for both TCR-T and CAR-T research.

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.